Institute of Molecular and Cell Biology, A*Agency for Science, Technology and Research, 61 Biopolis Drive, Proteos, Singapore 138648, Republic of Singapore.
Cancer Cell. 2010 Jul 13;18(1):52-62. doi: 10.1016/j.ccr.2010.04.028.
Overexpression of phosphatase of regenerating liver (PRL)-3 is associated with the progression of diverse human cancers. We show that the overexpression of PRL-3 protein is not directly associated with its transcript levels, indicating the existence of an underlying posttranscriptional regulation. The 5' untranslanted region (UTR) of PRL-3 mRNA possesses triple GCCCAG motifs capable of suppressing mRNA translation through interaction with PolyC-RNA-binding protein 1 (PCBP1), which retards PRL-3 mRNA transcript incorporation into polyribosomes. Overexpression of PCBP1 inhibits PRL-3 expression and inactivates AKT, whereas knockdown of PCBP1 causes upregulation of PRL-3 protein levels, activation of AKT, and promotion of tumorigenesis. An inverse correlation between protein levels of PRL-3 and PCBP1 in human primary cancers supports the clinical relevance.
肝再生磷酸酶-3(PRL-3)的过表达与多种人类癌症的进展有关。我们表明,PRL-3 蛋白的过表达与其转录水平没有直接关联,表明存在潜在的转录后调控。PRL-3 mRNA 的 5'非翻译区(UTR)具有三个 GCCCAG 基序,能够通过与多聚 C-RNA 结合蛋白 1(PCBP1)相互作用来抑制 mRNA 翻译,从而延迟 PRL-3 mRNA 转录物掺入多核糖体。PCBP1 的过表达抑制 PRL-3 的表达并使 AKT 失活,而 PCBP1 的敲低导致 PRL-3 蛋白水平上调、AKT 激活和促进肿瘤发生。在人类原发性癌症中,PRL-3 和 PCBP1 的蛋白水平之间呈负相关,支持其临床相关性。